George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.16
Bid: 5.16
Ask: 6.30
Change: 0.44 (8.32%)
Spread: 1.14 (22.093%)
Open: 5.58
High: 5.58
Low: 5.16
Prev. Close: 5.29
NOG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

22 Nov 2019 11:29

RNS Number : 3905U
GoldmanSachs International
22 November 2019
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NOSTRUM OIL & GAS PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

NOSTRUM OIL & GAS PLC

(d) Date dealing undertaken:

21 November 2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Purchases

3,078

0.2360 GBP

0.2360 GBP

1p ordinary

Sales

3,078

0.2400 GBP

0.2275 GBP

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

22 November 2019

Contact name:

Kashif Rafiq and Papa Lette

Telephone number:

+44(20) 7051 0547 / +44(20) 7774 7442

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERBBBDBLDDBGCD
Date   Source Headline
21st Apr 202211:51 amRNSNotice of Revised Full Year Results Date
13th Apr 20221:46 pmRNSPublication of Circular/Notice of General Meeting
13th Apr 202210:25 amRNSProposed Restructuring & Related Party Transaction
8th Apr 20224:40 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
6th Apr 20223:44 pmRNSRestatement of impairment charge in prior year
22nd Mar 20224:35 pmRNSPrice Monitoring Extension
21st Mar 20224:41 pmRNSSecond Price Monitoring Extn
21st Mar 20224:35 pmRNSPrice Monitoring Extension
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:36 pmRNSPrice Monitoring Extension
28th Feb 20224:41 pmRNSSecond Price Monitoring Extn
28th Feb 20224:37 pmRNSPrice Monitoring Extension
22nd Feb 20229:15 amRNSDirector Declaration
15th Feb 20224:41 pmRNSSecond Price Monitoring Extn
15th Feb 20224:36 pmRNSPrice Monitoring Extension
9th Feb 20224:41 pmRNSSecond Price Monitoring Extn
9th Feb 20224:35 pmRNSPrice Monitoring Extension
7th Feb 20227:00 amRNSReceipt of Consents in respect of Solicitation
4th Feb 20224:36 pmRNSPrice Monitoring Extension
28th Jan 20227:00 amRNSOperational Update for 4Q and FY2021
24th Jan 20224:42 pmRNSSecond Price Monitoring Extn
24th Jan 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20221:46 pmRNSConsent Solicitation relating to Senior Notes
20th Jan 20224:41 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
19th Jan 20225:36 pmRNSRelated Party Transaction update
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:36 pmRNSPrice Monitoring Extension
18th Jan 20224:41 pmRNSSecond Price Monitoring Extn
18th Jan 20224:36 pmRNSPrice Monitoring Extension
18th Jan 202212:26 pmRNSUpdate on accessions to lock-up agreement
5th Jan 20224:36 pmRNSPrice Monitoring Extension
23rd Dec 20214:59 pmRNSLock-up agreement and restructuring terms
21st Dec 20217:00 amRNSStatement regarding recent media speculation
17th Dec 20211:00 pmRNSExtension of Forbearance Agreement
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:35 pmRNSPrice Monitoring Extension
6th Dec 202111:45 amRNSExtension of Forbearance Agreement
6th Dec 20218:36 amRNSTR-1: Notification of major holdings
26th Nov 20214:41 pmRNSSecond Price Monitoring Extn
26th Nov 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20219:00 amRNSExtension of Forbearance Agreement
23rd Nov 20219:00 amRNSRE AGM vote on authorisation to allot shares
16th Nov 20217:00 amRNS9M 2021 Financial Results
9th Nov 20219:00 amRNSExtension of Forbearance Agreement
29th Oct 20217:00 amRNSOperational Update for 3Q and 9M 2021
19th Oct 20218:56 amRNSExtension of Forbearance Agreement
12th Oct 20214:40 pmRNSSecond Price Monitoring Extn
12th Oct 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.